Consider Suggesting Pioglitazone for Patients with Prediabetes and Prior Stroke
April 2016
You'll hear debate about using pioglitazone (Actos, etc) to decrease CV risk after an ischemic stroke...in patients WITHOUT diabetes.
New evidence suggests pioglitazone may improve CV outcomes in patients with a prior stroke or TIA and insulin resistance or PREdiabetes.
Using pioglitazone for about 5 years prevents a second stroke or heart attack in 1 in 36 of these patients, and slows progression to diabetes in 1 in 26...but does not decrease overall mortality.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote